Real World Clinical Outcomes for Metastatic Non-Small Cell Lung Cancer (mNSCLC) at IRST Italy

被引：0
|
作者：
Altini, M. [1 ]
Massa, I. [1 ]
Balzi, W. [1 ]
Gentili, N. [1 ]
Foca, F. [1 ]
Danesi, V. [1 ]
Manunta, S. [1 ]
Ejzykowicz, F. [2 ]
Chandwani, S. [3 ]
Burgio, M. [1 ]
Cravero, P. [1 ]
Verlicchi, A. [1 ]
Bronte, G. [1 ]
Crino, L. [1 ]
Delmonte, A. [1 ]
机构：
[1] IRCCS, Ist Sci Romagnolo Studio & Cura Tumor Irst, Meldola, Italy
[2] Merck & Co Inc, Oncol Prod Line, Core, Kenilworth, NJ USA
[3] Merck & Co Inc, Ctr Observat & Real World Evidence, Kenilworth, NJ USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
treatment pattern; real-world study; Outcomes;
D O I：
10.1016/j.jtho.2019.08.2369
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.16-04
引用
收藏
页码：S1065 / S1066
页数：2
相关论文
共 50 条
  • [41] IMPACT OF ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER (A/MNSCLC) ON PATIENTS IN THE US AND UK: SURVEY RESULTS
    Tapan, U.
    Wang, Y.
    Meng, Y.
    Yang, H.
    Shah, M.
    Bell, K.
    Liao, A.
    Ye, M.
    Solem, C.
    VALUE IN HEALTH, 2024, 27 (06) : S335 - S335
  • [42] Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Elderly Patients: Survival Analysis Based on Platinum Retreatment
    Linsalmeida, T.
    Fernandes, R.
    Faccio, A.
    Reis Filho, P.
    Oliveira, H.
    Tavares, F.
    Peria, F.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S310 - S310
  • [43] Real-world experience of the 6 weekly schedule (q6w) of pembrolizumab in patients (pts) with metastatic non-small cell lung cancer (mNSCLC)
    Tariq, Noor-Ul-Ain
    Anderson, Christian
    Gartside, Eleanor
    Wong, Helen
    Dobson, Lisa
    Anthonypillai, Marry
    Griffiths, Richard
    Pope, Anthony
    LUNG CANCER, 2022, 165 : S38 - S38
  • [44] COUGH, DYSPNEA, CHEST PAIN OR A COMPOSITE? ANALYSIS OF KEY SYMPTOMS IN METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC) CLINICAL TRIALS
    Castro, Y.
    Corey-Lisle, P. K.
    Holt, T.
    Mamolo, C.
    VALUE IN HEALTH, 2024, 27 (06) : S260 - S260
  • [45] Using real world data to examine outcomes in immunotherapy-treated patients with metastatic non-small cell lung cancer.
    Luciano, Sierra
    Haudenschild, Christian
    Kuranz, Seth
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Biomarker Testing, Treatment, and Outcomes in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Using a Real-World Database
    Bhandari, Naleen Raj
    Hess, Lisa M.
    He, Dan
    Peterson, Patrick
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (09): : 934 - +
  • [47] Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country
    Poh, Mau Ern
    How, Soon Hin
    Ho, Gwo Fuang
    Pang, Yong Kek
    Hasbullah, Harissa H.
    Tho, Lye Mun
    Nor, Ibtisam Muhamad
    Lim, Bee Chiu
    Ho, Kean Fatt
    Thiagarajan, Muthukkumaran
    Samsudin, Azlina
    Omar, Azza
    Ong, Choo Khoon
    Soon, Sing Yang
    Tan, Justin Yu Kuan
    Abidin, Muhammad Adil Zainal
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 31 - 41
  • [48] Real-world outcomes of patients with non-small cell lung cancer with and without intracranial metastatic disease: A retrospective cohort analysis
    Sherman, M.
    Das, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S414 - S415
  • [49] Treatment of metastatic ALK-positive non-small cell lung cancer: real-world outcomes in a single center study
    Kamali, Caroline
    Tsakonas, Georgios
    Hydbring, Per
    Jatta, Kenbugul
    Berglund, Anders
    Viktorsson, Kristina
    Lewensohn, Rolf
    De Petris, Luigi
    Ekman, Simon
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (11)
  • [50] Pembrolizumab in Metastatic Non-Small Cell Lung Cancer (NSCLC): Real World Data of Patient Outcomes from a District General Hospital
    Roberts, Christopher
    Hesford, James
    Lewis, Pippa
    Tillett, Tania
    Cox, R. Ashley
    LUNG CANCER, 2024, 190
12345